These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 9411321
21. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia]. Schambelan M, Sebastian A. Nephrologie; 1985; 6(3):135-7. PubMed ID: 3908957 [Abstract] [Full Text] [Related]
23. Hyperkalemia: therapeutic options in acute and chronic renal failure. Kemper MJ, Harps E, Müller-Wiefel DE. Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156 [Abstract] [Full Text] [Related]
24. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure]. Lifshits NL, Kutyrina IM. Ter Arkh; 1999 Jul; 71(6):64-7. PubMed ID: 10420461 [Abstract] [Full Text] [Related]
25. Pseudohypoaldosteronism with normal blood pressure. Shoker A, Morris G, Skomro R, Laxdal V. Clin Nephrol; 1996 Aug; 46(2):105-11. PubMed ID: 8869787 [Abstract] [Full Text] [Related]
26. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. Henger A, Tutt P, Riesen WF, Hulter HN, Krapf R. J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465 [Abstract] [Full Text] [Related]
28. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S, Bernheim J, Podjarny E. Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [Abstract] [Full Text] [Related]
29. Should beta-blockers be used to control hypertension in people with chronic kidney disease? Hart PD, Bakris GL. Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793 [Abstract] [Full Text] [Related]
30. [Is permanent renal function damage possible after hemorrhagic fever with renal syndrome?]. Ledina D, Bradarić N, Ivić I, Marasović D, Radović D, Ostojić-Bakotin V, Prgomet S. Acta Med Croatica; 2003 Sep; 57(5):365-8. PubMed ID: 15011462 [Abstract] [Full Text] [Related]
34. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. Choi MJ, Ziyadeh FN. J Am Soc Nephrol; 2008 Mar; 19(3):424-6. PubMed ID: 18216310 [Abstract] [Full Text] [Related]
37. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency]. Hottelart C, el Esper N, Achard JM, Pruna A, Fournier A. Nephrologie; 1999 Mar; 20(1):41-4. PubMed ID: 10081035 [Abstract] [Full Text] [Related]
38. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients. Mahajan SK, Mangla M, Kishore K. J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861 [Abstract] [Full Text] [Related]
39. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease. Svarstad E, Myking O, Ofstad J, Iversen BM. Scand J Urol Nephrol; 2002 Nov; 36(6):464-72. PubMed ID: 12623513 [Abstract] [Full Text] [Related]
40. [A new treatment of hyperkalemia in renal failure with selective beta 2-adrenergic stimulant, terbutaline sulfate]. Tanaka Y, Nagao M, Nishio T, Hashida E, Kashiwagi A, Shigeta Y. Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):353-8. PubMed ID: 2747008 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]